1. Inhibition of PrpSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.
- Author
-
Crozet, Carole, Yea-Lih Lin, Mettling, Clément, Mourton-Gilles, Chantal, Corbeau, Pierre, Lehmann, Sylvain, and Perrier, Véronique
- Subjects
- *
CHRONIC wasting disease , *PRIONS , *LENTIVIRUSES , *GENETIC transformation , *GENETIC mutation , *PROTEINS - Abstract
Currently, there is no treatment to cure transmissible spongiform encephalopathies. By taking advantage of the ‘prion-resistant’ polymorphisms Q171R and E219K that naturally exist in sheep and humans, respectively, we have evaluated a therapeutic approach of lentiviral gene transfer. Here, we show that VSV-G (vesicular stomatitis virus G glycoprotein) pseudotyped FIV-(feline immunodeficiency virus) derived vectors carrying the mouse Prnp gene in which these mutations have been inserted, are able to inhibit prion replication in chronically prion-infected cells. Because lentiviral tools are able to transduce post-mitotic cells such as neurons or cells of the lymphoreticular system, this result might help the development of gene- or cell-therapy approaches to prion disease. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF